TY -的T1 -两种表型预测prognosis in lung adenocarcinoma JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00569-2022 VL - 60 IS - 1 SP - 2200569 AU - Kalinke, Lukas AU - Janes, Sam M. Y1 - 2022/07/01 UR - //www.qdcxjkg.com/content/60/1/2200569.abstract N2 - A lung cancer patient's prognosis is defined by a combination of the cancer stage, which defines the cancer location and spread; the patient's performance status, acting as an indirect measure of their ability to tolerate treatment; and finally, more intrinsic tumour-related properties such as the local immune contexture and tumour genetic makeup. The latter two dictate whether immunotherapy and targeted agents are treatment options.Histopathological biomarkers can predict survival in patients with resected lung adenocarcinoma https://bit.ly/3JN2HzL ER -